Developing humanized mouse models for nnmt and SULT1A1
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00824
- Awardee
-
Gempharmatech LLC UEI H42SCKKGRTU3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $249,168
Award facts
- Opportunity
-
- Developing humanized mouse models for NNMT and SULT1A1 Solicitation · 75N95023Q00612 · Posted Aug 25, 2023
- Contract value 100% obligated
- $249,167.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- La Jolla, CA 92037, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $89,468 | |
| Other Administrative Action | $0 | |
| Original award | $159,700 |
About this award
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and determine the maximum tolerated dose for pharmacokinetic/pharmacodynamic (PK/PD) and efficacy experiments. The contract has a 12-month period of performance and does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95023P00824?
75N95023P00824 was awarded to Gempharmatech LLC by National Institute on Drug Abuse (National Institutes of Health) on September 22, 2023.
How much is contract 75N95023P00824 worth?
The government has obligated $249,168 on 75N95023P00824.
Which agency awarded contract 75N95023P00824?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00824, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00824 competed?
The extent of competition for 75N95023P00824 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award